Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Oxlumo Generic Name & Formulations
Legal Class
General Description
Pharmacological Class
How Supplied
Manufacturer
Generic Availability
Oxlumo Indications
Indications
Treatment of primary hyperoxaluria type 1 (PH1) to lower urinary and plasma oxalate levels.
Oxlumo Dosage and Administration
Adults and Children
Give by SC inj into abdomen, thigh, or upper arms; rotate inj sites. <10kg: loading dose: 6mg/kg once monthly for 3 doses; maintenance (begin 1 month after the last loading dose): 3mg/kg once monthly. 10–<20kg: loading dose: 6mg/kg once monthly for 3 doses; maintenance (begin 1 month after the last loading dose): 6mg/kg once every 3 months. ≥20kg: loading dose: 3mg/kg once monthly for 3 doses; maintenance (begin 1 month after the last loading dose): 3mg/kg once every 3 months. Hemodialysis patients: administer dose after session if given on dialysis days.
Oxlumo Contraindications
Not Applicable
Oxlumo Boxed Warnings
Not Applicable
Oxlumo Warnings/Precautions
Warnings/Precautions
Severe hepatic impairment (total bilirubin >3×ULN with any AST) or peritoneal dialysis patients: not studied. Pregnancy. Nursing mothers.
Oxlumo Pharmacokinetics
See Literature
Oxlumo Interactions
Not Applicable
Oxlumo Adverse Reactions
Adverse Reactions
Oxlumo Clinical Trials
See Literature
Oxlumo Note
Not Applicable
Oxlumo Patient Counseling
See Literature
Images
